MicroFSMA: An H2020 Project
MicroFSMA involves developing a microfluidic-based assay to isolate quality sperm from human semen specimens. The technology contains a PDMS-free microfluidic chip integrated with a computational framework. Microfluidics chip facilitates the separation of highly DNA intact quality sperm cells, and a computational framework provides the automated kinematics of swimming of sperm cells. The project was granted to Cherry Biotech, where the founder of Béez leads the project development. Further, we aim to translate the MicroFSMA project into a commercial product, particularly for quality sperm cell separation and semen analysis.
Interested in our adventure?
Beta testing invitation
Test our solution for free of cost. We encourage you to become part of our adventure and join our hand in clinical validation of the developed technology. For more information contact us.
Join us
Become an associate member. Our venture is looking forward to building a highly skilled team that can facilitate cutting-edge solutions to problems associated with reproductive health.
Computer Assisted Semen Analysis (CASA)
We provide image-processing+artificial intelligence (AI) based solutions that extract CASA parameters and additional parameters associated with sperm kinematic. We offer automation and lab-ready tools to advance your reproductive clinics.
